Imagine a new treatment for people with major depression who have not responded to existing treatments—one that acts rapidly and...
Read More
Carefully designed, exquisitely controlled experiments sometimes don't produce the result predicted in advance—the research “hypothesis” that is the starting point...
Read More
In the spring of 2019, The Food and Drug Administration granted approval for two breakthrough medicines that act rapidly to...
Read More
Researchers led by 2013 BBRF Young Investigator Conor Liston, M.D., Ph.D. , have just reported a surprising finding about the...
Read More
On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid...
Read More